Encore Medical Corporation to Present at the First Albany Capital Small Cap Orthopedic Conference

AUSTIN, Texas, March 17  /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) announced today that Kenneth W. Davidson, CEO and Chairman of the Board of Directors, and other members of Encore's Executive Management, will present at the First Albany Capital Small Cap Orthopedic Conference on Tuesday, March 21, 2006 at 2:00 p.m. central time.  The conference is being held at The Metropolitan Club in the Sears Tower in Chicago, Illinois.

The presentation will provide an overview of Encore's products, market opportunities and competitive position.  Attendance at the conference is only by invitation from First Albany Capital.

Encore Medical Corporation is a diversified orthopedic device company that develops, manufactures and distributes a comprehensive range of high quality orthopedic devices used by orthopedic surgeons, physicians, therapists, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries.  Through its Orthopedic Rehabilitation Division, Encore is a leading distributor of electrical stimulation and other orthopedic products used for pain management, orthopedic rehabilitation, physical therapy, fitness and sport performance enhancement. Encore's Surgical Implant Division offers a comprehensive suite of reconstructive joint products and spinal implants.  For more information, visit http://www.encoremed.com/ .

   Contact  Davis Henley, Vice President - Business Development
            [phone]
            



Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  These statements involve risks and uncertainties, such as quarterly fluctuations in operating results, the timely availability of new products, the impacts of competitive products and pricing, the ability to grow the distribution networks for the Company's products, the ability to continue to obtain long- term financing, and the ability to locate and integrate future acquisitions and other risks and uncertainties set forth in the Company's filings with the Securities and Exchange Commission.  These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein. 

DATASOURCE: Encore Medical Corporation



CONTACT: Davis Henley, Vice President - Business Development of Encore

Medical Corporation, [phone], or  



Web site:  http://www.encoremed.com/ 

Copyright